Sign In   |   Join ISAR
Site Search

Join us in Porto for the 31st ICAR!

IMPORTANT NOTICE:  In preparation for GDPR (General Data Protection Regulation), a new regulation for data protection and privacy which goes into effect May 25, 2018, an email notice has been sent by ISAR asking you to opt-in to receiving future emails.
Please click here for additional information.

 Alfandega Congress Center - "Best in Europe”

The 31st International Conference on Antiviral Research (ICAR), hosted by the International Society for Antiviral Research (ISAR), will take place at the Alfândega Congress Centre in Porto, Portugal. The conference will begin on Monday, June 11, 2018, and will conclude on Friday, June 15, 2018.

FINAL PROGRAM - Download Now!

View the Program-at-a-Glance for 2018 ICAR

 City of Porto – UNESCO World Heritage Site
 Banquet Dinner at Port Wine Cellar


Confirmed Speakers

Prof. William Britt - Neurodevelopmental Sequelae following Congenital CMV: Role of Virus-Induced Inflammation

Prof. Tijn Brummelkamp - The Identification of Viral Host Factors Using Haploid Genetics in Human Cells   

Prof. Sarah Butcher - A primer on cryo-EM and image reconstruction for antiviral drug development

Dr. Angela Ciuffi - Transcriptional profiling of HIV latency

Dr. Davide Corti - Tackling influenza with broadly neutralizing antibodies  

Dr. David Durantel - HBc and CAMs: a tale of "Swiss army-knife" protein and antivirals  

Prof. Ron Fouchier - Influenza virus resistance to neuraminidase inhibitors 

Sir Prof. Michael Jacobs - Ebola treatment: working in the dark under the spotlight  

Prof. David Kimberlin - Treatment of congenital CMV infection: new populations, new regimens, and new drugs

Prof. Percy Knolle - Mechanisms of Immune Dysfunction in Chronic Hepatitis B and Possible Immune Therapies  

Prof. Frank van Kuppeveld - ANTIVIRALS; a training network to structure PhD student education at the EU level

Prof. Randi Leavitt - Letermovir: Current State of the Art 

Prof. Philippe Lemey - Getting to the root of epidemic spread: an evolutionary perspective on pathogen emergence

Dr. Nicolas Manel - Avoidance of innate immune sensors by HIV-1

Prof. Jean Michel Pawlotsky - Hepatitis C virus: problem solved. And now?

Prof. Xavier Saelens - Treatment option for human RSV infections: small molecules, antibodies or something in between

Dr. Ole Schmeltz Søgaard - Latency and reactivation of HIV       

Dr. Marco Vignuzzi - Targeting viral infections using evolutionary rationale  

Prof. Annelies Wilder-Smith - All you need to know about the Zika virus

ISAR 2018 Awardees

Gertrude Elion Memorial Awardee: Prof. Paul GriffithsTreatment in immunocompromised hosts and resistance 

Antonin Holý Memorial Awardee: Prof. Chris Meier - From Nucleoside Monophosphate Prodrugs to Nucleoside Triphosphate Prodrugs – The Challenge, a Possible Solution and Further Improvements

William Prusoff Young Investigator Awardee: Dr. Ester Ballana - Regulation of Nucleotide Metabolism: From Virus Restriction to Therapeutic implications in HIV infection and Beyond

Women in Science Speaker Awardee: Dr. Desiree LaBeaud - Making the Invisible Visible: Arbovirus Transmission, Risk, Disease and Prevention in Kenya


The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.




Sign In